Article

Haag-Streit, Reliance Medical Products name Ernest Cavin president, CEO

Ernest Cavin, MBA, DBA, has been named president and chief executive officer of Haag-Streit USA and Reliance Medical Products, both based in Mason, OH.

Mason, OH-Ernest Cavin, MBA, DBA, has been named president and chief executive officer (CEO) of Haag-Streit USA and Reliance Medical Products, both based in Mason, OH.

“Haag-Streit and Reliance have achieved record sales, due to a commitment to offering the eye-care industry products they can trust,” Dr. Cavin said. “My goal is to remain true to those core principles, as medical devices become more high-tech and software-oriented. We will continue to focus on adding value and serving the needs of the eye-care community.”

Before joining Haag-Streit USA, Dr. Cavin held positions with Ciena Ltd., Ascom, Swisscom FixNet, and Lucent Technologies. A graduate of engineering school in Biel, Switzerland, Dr. Cavin earned his master of business administration degree at City University of Seattle in Bellevue, WA, and his doctor of business administration degree from Argosy University. He undertook additional training at Columbia University, New York, and the Kellogg School of Management of Northwestern University, Evanston, IL.

Haag-Streit, headquartered in Bern, Switzerland, manufactures optical instruments for ophthalmologists and optometrists. Reliance Medical Products, now a division of Haag-Streit, manufactures chairs, stools, and instrument delivery systems for medical practices.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
© 2025 MJH Life Sciences

All rights reserved.